Literature DB >> 25120779

Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis in cervical cancer cells in vitro and in vivo.

Ning Wang1, Heng Wei1, Duo Yin1, Yanming Lu1, Yao Zhang1, Di Jiang1, Yan Jiang1, Shulan Zhang1.   

Abstract

Cyclin D1b is one of two proteins translated from cyclin D1 transcripts (isoforms a and b) that are generated due to gene polymorphism. Our previous study has reported low cyclin D1b expression in cervical cancer tissue, with an expression level in moderately or poorly differentiated tissues that was significantly lower than that in well-differentiated tissues. However, the functional role of cyclin D1b in cervical cancer remains to be elucidated. In this study, using a cervical cancer cell line with stable expression of cyclin D1b, we found that upregulation of cyclin D1b initiated cell cycle arrest at the G0/G1 phase and induced apoptosis, thereby inhibiting cell proliferation and colony formation. Furthermore, xenograft transplantation experiments in nude mice demonstrated that cyclin D1b upregulation inhibited cancer growth and induce apoptosis in vivo. In conclusion, the present study indicates anti-tumor effects of cyclin D1b in cervical cancer, suggesting that cyclin D1b may represent a potential therapeutic target for cervical cancer.

Entities:  

Keywords:  Cyclin D1b; apoptosis; cervical cancer; proliferation

Mesh:

Substances:

Year:  2014        PMID: 25120779      PMCID: PMC4129014     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

Review 1.  Linking cyclins to transcriptional control.

Authors:  Olivier Coqueret
Journal:  Gene       Date:  2002-10-16       Impact factor: 3.688

Review 2.  Alteration of cell cycle in cervical tumor associated with human papillomavirus: cyclin-dependent kinase inhibitors.

Authors:  Nam Hoon Cho; Young Tae Kim; Jae Wook Kim
Journal:  Yonsei Med J       Date:  2002-12       Impact factor: 2.759

3.  Alternative cyclin D1 forms a and b have different biological functions in the cell cycle of B lymphocytes.

Authors:  Céline Lévêque; Véronique Marsaud; Jack-Michel Renoir; Brigitte Sola
Journal:  Exp Cell Res       Date:  2007-04-24       Impact factor: 3.905

4.  Human papillomavirus: epidemiology and public health.

Authors:  Mark Schiffman; Philip E Castle
Journal:  Arch Pathol Lab Med       Date:  2003-08       Impact factor: 5.534

5.  Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.

Authors:  David A Solomon; Ying Wang; Sejal R Fox; Tah C Lambeck; Sarah Giesting; Zhengdao Lan; Adrian M Senderowicz; Claudio J Conti; Erik S Knudsen
Journal:  J Biol Chem       Date:  2003-05-12       Impact factor: 5.157

6.  Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.

Authors:  Craig J Burd; Christin E Petre; Lisa M Morey; Ying Wang; Monica P Revelo; Christopher A Haiman; Shan Lu; Cecilia M Fenoglio-Preiser; Jiwen Li; Erik S Knudsen; Jiemin Wong; Karen E Knudsen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

Review 7.  Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.

Authors:  Mako Narisawa-Saito; Tohru Kiyono
Journal:  Cancer Sci       Date:  2007-07-23       Impact factor: 6.716

8.  Alternate splicing produces a novel cyclin D1 transcript.

Authors:  D C Betticher; N Thatcher; H J Altermatt; P Hoban; W D Ryder; J Heighway
Journal:  Oncogene       Date:  1995-09-07       Impact factor: 9.867

9.  An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.

Authors:  Fengmin Lu; Andrew B Gladden; J Alan Diehl
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

10.  Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.

Authors:  Sophie Krieger; Juliette Gauduchon; Mikel Roussel; Xavier Troussard; Brigitte Sola
Journal:  BMC Cancer       Date:  2006-10-06       Impact factor: 4.430

View more
  5 in total

Review 1.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

2.  Expression Of Cyclin D1 Protein Isoforms And Its Prognostic Significance In Cervical Cancer.

Authors:  Jiahui Gu; Xinyu Zhang; Zhuo Yang; Ning Wang
Journal:  Cancer Manag Res       Date:  2019-10-24       Impact factor: 3.989

3.  The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells.

Authors:  Chengli Liu; Hui Zhang; Xiaoxia Zang; Cheng Wang; Yalin Kong; Hongyi Zhang
Journal:  Diagn Pathol       Date:  2015-04-18       Impact factor: 2.644

Review 4.  Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities.

Authors:  Caiguo Zhang; Fan Zhang
Journal:  Protein Cell       Date:  2014-12-06       Impact factor: 14.870

5.  GSK-J4-Mediated Transcriptomic Alterations in Differentiating Embryoid Bodies.

Authors:  Chanchal Mandal; Sun Hwa Kim; Sung Chul Kang; Jin Choul Chai; Young Seek Lee; Kyoung Hwa Jung; Young Gyu Chai
Journal:  Mol Cells       Date:  2017-10-17       Impact factor: 5.034

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.